26Jun
Financial Daily Dose 6.25.2019 | Top Story: Allergan and AbbVie Combine Forces in $63 Billion Deal
Massive pharma news to start the day, with AbbVie announcing that it’s reached a deal to buy Allergan for roughly $63 billion. The tie-up is seen as giving AbbVie a “dominant position in the $8 billion-plus market for Botox and other beauty drugs” is...
By:
Robins Kaplan LLP
Related
The U.S. District Court for the Eastern District of New York recently rejected the government’s arg...
Read More >
In a decision C-55/18 issued by the Court of Justice of the European Union (ECJ) on 14 May 2019, the...
Read More >
The recent judgment of the High Court in the Oval Estates case has highlighted the importance to dev...
Read More >
In a welcomed attempt to align their approaches, the antitrust enforcers of the European Competition...
Read More >
In the UK, the definition of "worker" includes both employees and anyone else working under a contra...
Read More >
The IRS’s informal FAQs provide comfort that an acquirer, including affiliated companies treated as...
Read More >